HLA-C and neoplasm: Unlike CAR-Ts, TCR-T cells recognize MHC-presented antigens in a conventional way through their TCR, initiating a cascade of immune response reactions, including cytotoxic pathways, elevated cytokine production, and immune activation, which hampers tumor progression [204].